BSE filing, NSE: DRAGARWQ. Summary written from the filing by ALFA Finder's alert engine.
Dr. Agarwal's Eye Hospital Ltd: key numbers
- Share price
- ₹5,112.20
- Market cap
- ₹2,403 Cr
- Revenue (annual)
- ₹470.9 Cr
- Net profit (annual)
- ₹70.10 Cr
- P/E (TTM)
- 31.5×Sector 52.0×
- Promoter holding
- 72.67%+0.00% QoQ
- FII holding
- 2.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwal's Eye Hospital Ltd
All →Dr. Agarwal's Eye Hospital Acquisition Worth ₹711.2 Cr
Dr. Agarwal's Eye Hospital Limited has completed its amalgamation with Dr. Agarwal's Health Care Limited, with the transaction valued at ₹711.21 Crore.
- Value
- ₹711.2 Cr
Dr. Agarwal's Eye Hospital Acquisition
Dr. Agarwal's Eye Hospital announced the effectiveness of its Scheme of Amalgamation starting November 01, 2026, and fixed a record date for share allotment.
Dr. Agarwal's Eye Hospital Other Announcement
The company submitted its quarterly shareholding pattern as mandated by SEBI. The filing provides a breakdown of shareholdings among promoters and the public.
Dr. Agarwal's Eye Hospital Acquisition
The NCLT Chennai Bench has sanctioned the Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited. The company awaits the order copy.
Dr. Agarwal's Eye Hospital Annual General Meeting
Dr. Agarwal's Eye Hospital Limited held its 32nd Annual General Meeting on September 09, 2026. The meeting concluded with the approval of six business resolutions.
Dr. Agarwal's Eye Hospital Business Update
Dr. Agarwals Eye Hospital inaugurated its new Pinhole Pupilloplasty Centre in Chennai. This facility provides advanced specialized clinical treatments for patients with complex corneal conditions.
Other board meeting date announcements
All →Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.
EPL Board Meeting Date
EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.